Robinson Value Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,947
Closed -$767K 71
2023
Q4
$767K Hold
4,947
0.5% 46
2023
Q3
$737K Hold
4,947
0.55% 46
2023
Q2
$667K Hold
4,947
0.48% 44
2023
Q1
$788K Hold
4,947
0.61% 38
2022
Q4
$799K Hold
4,947
0.69% 39
2022
Q3
$664K Hold
4,947
0.66% 42
2022
Q2
$758K Hold
4,947
0.7% 37
2022
Q1
$802K Hold
4,947
0.62% 41
2021
Q4
$670K Sell
4,947
-19
-0.4% -$2.24K 0.55% 45
2021
Q3
$536K Buy
4,966
+19
+0.4% +$2.17K 0.48% 48
2021
Q2
$557K Hold
4,947
0.45% 46
2021
Q1
$535K Hold
4,947
0.44% 46
2020
Q4
$530K Buy
+4,947
New +$475K 0.5% 43
2019
Q4
$531K Buy
+6,000
New +$498K 0.51% 43
2019
Q2
$436K Buy
+6,000
New +$472K 0.42% 49
2018
Q3
$596K Hold
6,304
0.55% 45
2018
Q2
$584K Hold
6,304
0.53% 42
2018
Q1
$597K Sell
6,304
-1,696
-21% -$186K 0.55% 42
2017
Q4
$774K Hold
8,000
0.68% 44
2017
Q3
$711K Sell
8,000
-300
-4% -$22.8K 0.65% 43
2017
Q2
$602K Sell
8,300
-2,521
-23% -$169K 0.56% 48
2017
Q1
$705K Hold
10,821
0.65% 47
2016
Q4
$678K Buy
+10,821
New +$661K 0.64% 51

Other funds holding ABBV

Robinson Value Management's ABBV Position: Q1 2024 in Review

Robinson Value Management sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 4,947 shares — an estimated $767K sold.

Robinson Value Management first reported a position in ABBV in Q4 2016 and held it in 23 quarters. The position peaked at $802K in Q1 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Robinson Value Management reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
  • Robinson Value Management sold 4,947 AbbVie shares in Q1 2024, an estimated $767K.
  • Robinson Value Management first reported a position in AbbVie in Q4 2016 and held it in 23 quarters.
  • Robinson Value Management's AbbVie position peaked at $802K in Q1 2022.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Robinson Value Management's 13F filing for Q1 2024, filed 15 Apr 2024.